Rubedo Life Science

View the org chart displaying its 8 main executives

Most searched biographies at Rubedo Life Science

• Marco Quarta, Co-Founder and Chief Executive Officer
• Mark Gallop, Co-Founder, Chairman of the Board
• Robert Gould, Director

Create your alert
to follow the executive moves at Rubedo Life Science.

Rubedo Life Science has 2,298 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Grey Wolf Therapeutics has just announced a $50 Million fundraising (posted on May 25 2024).
• AbbVie has acquired Landos Biopharma (posted on May 25 2024).
• AltruBio has just announced a $225 Million fundraising (posted on May 24 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Rubedo Life Science

Social media about Rubedo Life Science

• Rubedo Life Science on Wikipedia, Google News & Yahoo Finance
• Rubedo Life Science on LinkedIn, Twitter & YouTube

Call Rubedo Life Science at +1 912...

View the org chart

Register to receive your alert

Report an error